Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Outset Medical
OM
$92.5M
| $2.66M | ﹤0.01% |
9,640
+7,507
| +352% | +$2.76M |
|
1852
InfuSystem Holdings
INFU
$186M
| $2.66M | ﹤0.01% |
343,209
+300
| +0.1% | +$2.76K |
|
1853
Organogenesis Holdings
ORGO
$301M
| $2.66M | ﹤0.01% |
1,248,400
+75,002
| +6% | +$185K |
|
1854
Allot
ALLT
$386M
| $2.65M | ﹤0.01% |
984,462
+13,656
| +1% | +$44.2K |
|
|
SEMR
1855
DELISTED
Semrush
SEMR
| $2.65M | ﹤0.01% |
263,500
+127,300
| +93% | +$1.12M |
|
1856
Monarch Casino & Resort
MCRI
$2.24B
| $2.64M | ﹤0.01% |
35,583
-7,117
| -17% | -$542K |
|
1857
Bowman Consulting
BWMN
$480M
| $2.63M | ﹤0.01% |
91,600
+40,162
| +78% | +$1.05M |
|
1858
Arhaus
ARHS
$1.12B
| $2.62M | ﹤0.01% |
316,128
+61,728
| +24% | +$745K |
|
1859
Outfront Media
OUT
$5.61B
| $2.62M | ﹤0.01% |
164,080
+143,354
| +692% | +$2.51M |
|
|
DCH
1860
Dauch Corp
DCH
$1.38B
| $2.62M | ﹤0.01% |
335,100
-43,800
| -12% | -$376K |
|
1861
Rigel Pharmaceuticals
RIGL
$693M
| $2.61M | ﹤0.01% |
197,872
+118,022
| +148% | +$1.88M |
|
1862
Alpha Pro Tech
APT
$50.4M
| $2.61M | ﹤0.01% |
627,465
+66,002
| +12% | +$274K |
|
1863
Omega Flex
OFLX
$305M
| $2.6M | ﹤0.01% |
23,380
-1,400
| -6% | -$152K |
|
1864
Data I/O
DAIO
$30.4M
| $2.6M | ﹤0.01% |
524,043
-20,600
| -4% | -$90.2K |
|
1865
Fulgent Genetics
FLGT
$500M
| $2.59M | ﹤0.01% |
82,954
+12,554
| +18% | +$404K |
|
1866
American States Water
AWR
$3.32B
| $2.59M | ﹤0.01% |
+29,100
| New | +$2.66M |
|
1867
SI-BONE Inc
SIBN
$818M
| $2.58M | ﹤0.01% |
+131,400
| New | +$2.33M |
|
1868
Orion Energy Systems
OESX
$41.5M
| $2.58M | ﹤0.01% |
127,061
-1,410
| -1% | -$26.7K |
|
1869
China Yuchai International
CYD
$1.74B
| $2.58M | ﹤0.01% |
326,780
-27,500
| -8% | -$230K |
|
1870
World Kinect Corp
WKC
$2B
| $2.57M | ﹤0.01% |
100,700
+63,300
| +169% | +$1.72M |
|
|
PWOD
1871
DELISTED
Penns Woods Bancorp
PWOD
| $2.56M | ﹤0.01% |
110,957
-3,652
| -3% | -$94.8K |
|
1872
Quanterix
QTRX
$175M
| $2.56M | ﹤0.01% |
227,400
+123,000
| +118% | +$1.57M |
|
1873
Manchester United
MANU
$3.9B
| $2.56M | ﹤0.01% |
115,600
-358,700
| -76% | -$8.13M |
|
|
ALPN
1874
DELISTED
Alpine Immune Sciences Inc
ALPN
| $2.55M | ﹤0.01% |
330,294
-2,600
| -0.8% | -$20.7K |
|
1875
Manitowoc
MTW
$514M
| $2.55M | ﹤0.01% |
149,149
-146,700
| -50% | -$2.2M |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.